What is the management of oleander seed poisoning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Oleander Seed Poisoning

The management of oleander seed poisoning should focus on administering digoxin-specific antibody fragments (digoxin-Fab), which is reasonable for treating yellow oleander poisoning according to the 2023 American Heart Association guidelines. 1

Initial Assessment and Stabilization

  • Recognize symptoms: Look for gastrointestinal symptoms, confusion, hyperkalemia, and cardiac conduction abnormalities including:

    • Bradyarrhythmias
    • Atrioventricular nodal block
    • Ventricular tachycardia/fibrillation
    • Asystole
  • Continuous ECG monitoring: Monitor for at least 24 hours to detect arrhythmias; longer monitoring for severe cases 2

  • Laboratory evaluation:

    • Serum potassium levels (both hypokalemia and hyperkalemia can occur)
    • Serum digoxin levels (can cross-react with oleander cardiac glycosides)
    • Renal function tests

Specific Treatment Algorithm

  1. Digoxin-specific antibody fragments (digoxin-Fab):

    • First-line treatment for life-threatening oleander poisoning 1
    • Dosing: For yellow oleander, 1200 mg (30 vials) has been used in clinical studies 1
    • Expect dysrhythmia resolution within 30-45 minutes in most cases
  2. Cardiac management:

    • For bradydysrhythmias:

      • Atropine may be reasonable (Class 2b recommendation, Level C-LD evidence) 1
      • Electrical pacing may be considered if atropine fails (Class 2b recommendation) 1
    • For ventricular dysrhythmias:

      • Lidocaine or phenytoin may be reasonable until digoxin-Fab can be administered (Class 2b recommendation) 1
  3. Electrolyte management:

    • Correct hyperkalemia with insulin-dextrose infusion
    • Avoid calcium administration for hyperkalemia as it increases risk of cardiac arrhythmias 2
    • Correct hypokalemia if present as it can worsen cardiac glycoside toxicity
  4. Gastrointestinal decontamination:

    • Single-dose activated charcoal is likely beneficial if administered early 2
    • The role of multiple-dose activated charcoal remains controversial 2

Special Considerations

  • Oxygen therapy: Provide supportive oxygen as needed, but be aware that excessive oxygen may not be beneficial in cellular toxins

  • Fluid management: Correct dehydration with normal saline and maintain adequate renal perfusion 2

  • Antiemetics: Control severe vomiting as needed 2

  • Avoid hemodialysis: Extracorporeal removal methods including hemodialysis, hemofiltration, hemoperfusion, or plasmapheresis are not recommended (Class 3: No Benefit) 1

Prognosis and Monitoring

  • Mortality rates vary but can be significantly reduced with proper treatment
  • In a study of 300 patients with yellow oleander seed ingestion, 46% developed arrhythmias with sinus bradycardia being the most common (49.27%) 3
  • Median hospital stay is approximately 5 days, with most patients (85.33%) having normal ECG at discharge 3

Pitfalls to Avoid

  1. Delaying digoxin-Fab administration: Early administration is critical for severe poisoning

  2. Calcium administration: Avoid intravenous calcium for hyperkalemia as it may precipitate life-threatening arrhythmias 2

  3. Inadequate monitoring: Patients may develop delayed cardiac toxicity; continuous monitoring for at least 24 hours is essential

  4. Underestimating severity: The number of seeds ingested does not reliably predict ECG changes or clinical severity 3

  5. Premature discharge: Ensure cardiac rhythm has stabilized before discharge

The evidence strongly supports the use of digoxin-Fab as the cornerstone of treatment for oleander poisoning, with supportive measures for cardiac arrhythmias and electrolyte abnormalities as needed.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of yellow oleander poisoning.

Clinical toxicology (Philadelphia, Pa.), 2009

Research

Cardiovascular effects of yellow oleander ingestion.

Journal of the Indian Medical Association, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.